Skip to content

Clinical trials

Pulmonary Fibrosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: Netherlands Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20071
20081
20101
20112
20205
20211
20222
20234
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting4
Terminated3
Unknown status3
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Erasmus Medical Center4
Bristol-Myers Squibb3
St. Antonius Hospital2
University Medical Center Groningen2
Amgen1
Amsterdam UMC, location VUmc1
Avalyn Pharma Inc.1
Centocor, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis23
Idiopathic Pulmonary Fibrosis10
Lung Diseases, Interstitial6
Sarcoidosis2
Alveolitis, Extrinsic Allergic1
Arthritis, Rheumatoid1
COVID-191
Connective Tissue Diseases1
Fibrosis1
Idiopathic Interstitial Pneumonias1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.